Can ritalin Jump-Start the brain after a coma?

NCT ID NCT03814356

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether a stimulant drug (methylphenidate, also known as Ritalin) given through an IV can safely help people with severe brain injuries regain consciousness. Ten adults in a coma or minimally conscious state will receive increasing doses to check for side effects like dangerous spikes in blood pressure or brain pressure. The study is too small to prove the drug works, but it lays the groundwork for future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
methylphenidate (Ritalin) given intravenously
What this could lead to
If safe and effective, this could point toward a treatment to help awaken patients with severe brain injuries.
What could go wrong
This is a very early Phase 1 safety study with only 10 participants, so it cannot prove the drug works. Risks include high blood pressure, fast heart rate, and increased brain pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANOXIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.